HLS Therapeutics's dividends per share for the
three
months ended in Dec. 2023 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.07. Its Dividend Payout Ratio for the
three
months ended in Dec. 2023 was 0.00. As of today, HLS Therapeutics's Dividend Yield % is 1.05%.
Warning Sign:
HLS Therapeutics Inc stock dividend yield is close to 3-year low.
During the past 12 months, HLS Therapeutics's average Dividends Per Share Growth Rate was -52.40% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -19.50% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 10.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of HLS Therapeutics was 59.00% per year. The lowest was -19.50% per year. And the median was 22.80% per year.
For more information regarding to dividend, please check our Dividend Page.
HLS Therapeutics Dividends per Share Historical Data
The historical data trend for HLS Therapeutics's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of HLS Therapeutics's Dividends per Share
For the Drug Manufacturers - Specialty & Generic subindustry, HLS Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HLS Therapeutics's Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, HLS Therapeutics's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where HLS Therapeutics's Dividend Yield % falls into.
HLS Therapeutics Dividends per Share Calculation
Dividends paid to per common share.
HLS Therapeutics (OTCPK:HLTRF) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
HLS Therapeutics's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of HLS Therapeutics was 0.25. The lowest was 0.25. And the median was 0.25.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
During the past 13 years, the highest Dividend Yield of HLS Therapeutics was 15.69%. The lowest was 0.32%. And the median was 2.05%.
Warning Sign:
HLS Therapeutics Inc stock dividend yield is close to 3-year low.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HLS Therapeutics Dividends per Share Related Terms
Thank you for viewing the detailed overview of HLS Therapeutics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
HLS Therapeutics (HLS Therapeutics) Business Description
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HLTRF has been successfully added to your 